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ABSTRACT 
The use of conventional synthetic insecticides is facing increased scrutiny 
due to environmental and mammalian health concerns along with resistance to 
target insects. This has led to an investigation of alternative control measures to 
combat both economically and medically important arthropods. Octopamine, a 
biogenic amine, has significant physiological functions in invertebrates, including 
insects, and signals through G-protein-coupled receptors (GPCRs).  Co-evolution of 
plants with insects has led to plants adapting defensive mechanisms to deter 
herbivore, microbial, or viral attack. This is sometimes accomplished via the 
production of essential oils that are composed of a variety of compounds, in 
particular monoterpenoids, sesquiterpenoids and aromatic compounds. Here we 
report on the functional coupling of a ligand-independent α-adrenergic-like 
octopamine receptor from the American cockroach and its expression in the yeast, 
Saccharomyces cerevisiae.  This expression system allows us to screen a large 
number of compounds to determine efficacy at this octopamine receptor.  We have 
found many monoterpenoids, sesquiterpenoids and aromatic compounds from 
essential oils that interact with this octopamine receptor and may account for their 
insecticidal action in this insect.  
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CHAPTER 1.  General Introduction 
Thesis Organization 
This thesis is organized into four chapters.  Chapter 1 is a general 
introduction chapter providing background information.  Chapter 2 “High-throughput 
screening of plant essential oil constituents against the α-adrenergic-like octopamine 
receptor from Periplaneta americana” is a chapter that is intended to be submitted to 
the journal Pesticide Biochemistry and Physiology.  Chapter 3 is the general 
conclusion, providing a synopsis of the research conducted in Chapter 2 and the 
appendix and outlining further research.  The appendix entitled “The ability of 
sesquiterpenoids to interact with a α-adrenergic-like octopamine receptor from the 
American cockroach Periplaneta americana” presents research similar to that 
presented in Chapter 2; however, it shows the ability of sesquiterpenoids to interact 
with a constitutively active octopamine receptor. 
Natural Insecticides 
In recent years there has been a decrease in the use of some conventional 
synthetic insecticides as the result of governmental restrictions, like the 
establishment of the Food Quality Protection Act of 1996.  This act limited the uses 
of many synthetic insecticides on the market as the result of the growing public 
concern about the safety of conventional insecticides.  Historically, synthetic 
insecticides have played a pivotal role in the protection of the world’s food supply 
and public health by preventing herbivory and arthropod-vectored diseases.  
Increased restriction of these compounds is creating an opening in the market place 
for safe, novel, and biorational compounds for pest control.  The following review will 
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focus on the utilization of naturally occurring terpenoid chemistries and their 
insecticidal potential at an octopamine receptor. 
Essential Oils 
Plant materials have historically been used to address pest problems in both 
agriculture and public health dating back 150 years in North America and Europe but 
thousands of years in China, Egypt, Greece, and India.  Botanical products that are 
currently available on the market are in the form of pyrethrum, rotenone, neem, and 
essential oils (Isman 2000, Isman 2006).  Here the focus will be on essential oils and 
their components.  Essential oils are the lipophilic liquids that are characterized by a 
strong odor and are commonly extracted by steam distillation; however, other 
extraction methods are available.  Essential oils are stored in multiple plant 
structures and cells; they can be extracted from various tissues or plant foliage 
(Bakkali et al. 2008).  Essential oils are typically complex mixtures of 
terpenes/terpenoids but some include related aromatic compounds.  In the context 
of this overview, terpene will be used interchangeably with terpenoid.  Essential oil 
terpenoids are generally in the form of monoterpenoids (10 carbons) and 
sesquiterpenoids (15 carbons).  The precise terpenoid composition of the oil may 
depend on the oil’s age, the environmental conditions with relation to the plant and 
its growth, and the age or cycle of the plant (Bakkali et al. 2008).  It was originally 
thought that essential oils were not important in the plant; however, the plant 
allocates significant energy to their production.   It has been determined that 
essential oils play a pivotal role as antimicrobials, as attractants to entice beneficial 
insects (pollinators and natural enemies), and for prevention of plant feeding by 
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insects and other herbivores (Isman 2000, Isman 2006, Bakkali et al. 2008).  The 
reduced toxicity risk of essential oils is evident because they are commonly used as 
food additives, in cosmetics and fragrances, in household cleaning products, as well 
as in pharmaceuticals (Chan 2001, Bakkali et al. 2008).  Since essential oils are 
routinely utilized, many of them can be found on the United State Environmental 
Protection Agency’s exempt lists (25b and 4a) and are commonly accepted as being 
“safe”.  According to Bakkali et al. (2008), more than 3,000 essential oils are known 
and approximately 300 are commercially important. 
Understanding the insecticidal mode of action of these compounds will help in 
the development of new applications in agriculture and human health.  Previous 
studies have indicated that the compounds may have a neurotoxic mode of action 
(Lee et al. 1997).  Several studies have been performed assessing different modes 
of neurotoxic action.  These studies included the compound’s ability to inhibit the 
enzyme acetylcholinesterase, leading to an increased concentration of acetylcholine 
in the synaptic cleft (Miyazawa et al. 1997, Miyazawa and Yamafuji 2005, Picollo et 
al. 2008, Siramon et al. 2009, Fujiwara et al. 2010, Lopez and Pascual-Villalobos 
2010).  Another study evaluated the ability of essential oil components to affect 
chloride conductance by altering the γ-aminobutyric acid (GABAA) receptor (Priestley 
et al. 2003).  Finally, the ability of these compounds to compete for binding and 
second-messenger production at octopamine receptors (Enan 2001, Kostyukovsky 
et al. 2001, Bischof and Enan 2004, Price and Berry 2006), and tyramine receptors 
(Enan 2005a) has been investigated. 
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Essential oils: Terpenoids 
Diverse functions of these secondary metabolites may be indicated by the 
diversity of their chemical structures.  Terpenoids are synthesized from five-carbon 
units, commonly referred to as isoprene units; an example of this is shown in Figure 
1a.    The coupling of these isoprene units can lead to structures that have 5 – 40 
carbons (Table 1).  Terpenoids are commonly joined in a head-to-head fusion of the 
isoprene units but head-to-tail and head-to-middle fusions are also possible, as 
indicated in Figure 1b.  The biosynthetic precursors of these compounds are 
isopentenyl diphosphate (IPP) and its allylic isomer dimethylallyl diphosphate 
(DMAPP); their structures are shown in Figure 2.  Coupling reactions of these two 
compounds results in the formation of the various terpenoid classes, listed in Table 
1.  Coupling of IPP along with DMAPP by prenyltransferase to form geranyl 
diphosphate in the synthesis of monoterpenoids, and the addition of another IPP 
would lead to farnesyl diphosphate in the production of sesquiterpenoids (Figure 2).  
Geranyl and farnesyl diphosphate yield the basic structural backbone that can be 
targeted by enzymes to produce compounds that are cyclic or acyclic.  Furthermore, 
oxidative enzymes, usually of the cytochrome P450 family, can act on these 
skeleton backbones to add functional groups like acids, alcohols, aldehydes, 
ketones, esters, epoxides, ethers, and acetates.  The diversity of essential oil 
components is related to these enzymes (Chappell 1995, Dewick 1997, Croteau et 
al. 2000). 
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Essential oils: Aromatic compounds 
The second class of compounds that make up the essential oils are the 10-
carbon aromatic compounds.  Aromatic compounds utilize the shikimic acid pathway 
to synthesize the three aromatic amino acids: L-phenylalanine, L-tyrosine, L-
tryptophan.  This pathway is found in plants and microorganisms but not in humans, 
thus the reason why these amino acids must be obtained in our diet.  In particular, 
phenylalanine and tyrosine are responsible for the phenylpropane/phenylpropene 
units that are the building blocks for the aromatic compounds found in essential oils.  
These compounds are synthesized by removing the nitrogen group via deamination 
of the amino acid.  Deamination of phenylalanine leads to cinnamic acid, while the 
deamination of tyrosine leads to 4-coumaric acid.  These compounds act as lead 
structures onto which functional groups are added by a variety of plant enzymes. 
Cinnamic acid can be reduced to cinnamyl alcohol and used for a group of 
compounds known as phenylpropene derivatives.  Further reduction of cinnamyl 
alcohol can result in a different position of the double bond, leading to allylphenols 
(such as eugenol), methylene dioxyphenyl compounds (such as saffrole),or 
prophenol compounds (such as anethole) (Dewick 1997).  In-depth examples of the 
synthesis pathway for the aromatic compounds can be found in Dewick, 1997.  
Octopamine: A vital biogenic amine 
Octopamine, p-hydroxyphenyl ethanolamine, is a biogenic monoamine that 
was first discovered and isolated from the salivary glands of the octopus (Octopus 
vulgaris) (Erspamer and Boretti 1951).  The precise function of octopamine in this 
animal is unknown, but a vast amount of knowledge of octopamine has been 
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revealed in invertebrates, including insects.  These functions can be emphasized by 
octopamine’s ability to act as a neurotransmitter, neuromodulator and 
neurohormone.  One of the most important physiological responses that has been 
attributed to octopamine is its involvement in the “fight or flight” mechanism of the 
insect.  The role of octopamine in this highly important survival mechanism has led 
to this compound to be extensively compared to amines involved in the adrenergic 
system, particularly norepinephrine (Baxter et al. 1999, Roeder 1999, Roeder et al. 
2003, Roeder 2005).  Octopamine’s importance to invertebrates has been covered 
in multiple reviews, which will be used as the foundation for the following discussion 
(Evans and Robb 1993, Roeder 1999, Roeder et al. 2003, Evans and Maqueira 
2005, Roeder 2005, Farooqui 2007). 
Octopamine: Synthesis, degradation, and location. 
Octopamine is synthesized from the amino acid tyrosine when tyrosine is 
targeted by tyrosine decarboxylase to form tyramine.  The formation of tyramine is 
the rate-limiting step in the synthesis of octopamine.  Tyramine is the substrate for 
tyramine-β-hydroxylase which can form octopamine (Roeder 1999, Blenau and 
Baumann 2001, Blenau and Baumann 2003, Roeder et al. 2003, Roeder 2005).  A 
salvage pathway has been identified to bypass the activity of tyrosine 
decarboxylase.  This salvage pathway uses dopamine to make tyramine (Roeder 
2005).  The inactivation of octopamine, in most insects, is via re-uptake into the pre-
synaptic neuron via specialized transporters.  Certain compounds have been shown 
to affect these transporters leading to deleterious effects in the insect; compounds 
include those found in St. John’s Wort (Roeder 2005) and cocaine (Nathanson et al. 
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1993, McClung and Hirsh 1998).  Monoamine oxidases (MAOs) are the common 
inactivation pathway of adrenergic compounds in mammalian tissues but are not 
believed to inactivate octopamine or tyramine (Roeder et al. 2003, Roeder 2005).     
The distribution of biogenic amines in the insect and other invertebrates is 
similar to their distribution in mammalian tissues.  That is, a few neurons will supply 
large areas of the nervous tissue with the biogenic amine.  Octopamine has been 
suggested to be released by 40 -100 neurons in the insect nervous system.  The 
majority of octopamine-releasing cells are in the dorsal unpaired median (DUM) and 
ventral unpaired median (VUM) neurons.  These few cells are involved in distribution 
of octopamine to all peripheral organs and the central nervous system of the insect.  
It is thought that octopamine-containing neurons in the subesophageal ganglion 
supply the insect’s brain with octopamine (Konings et al. 1988, Monastirioti et al. 
1996, Roeder et al. 2003, Roeder 2005, Farooqui 2007).  This has been further 
classified based on clusters in the brain, and it suggests that the location of the 
neurons differ between species of insects (Farooqui 2007).  The thoracico-
abdominal ganglion is responsible for distributing octopamine to the peripheral 
tissues to perform various physiological functions (Roeder et al. 2003, Roeder 2005, 
Farooqui 2007). 
Octopamine: Receptors and signal transduction 
Octopamine exerts its physiological response through the family of G protein-
coupled receptors (GPCRs).  GPCRs are of significant importance in mammalian 
tissues as they are a large class of membrane receptors with multiple forms of 
ligands and are involved in a wide variety of physiological functions.  The 
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dysfunction of these membrane receptors can lead to a variety of human diseases; 
as a result it has been estimated that 30-45% of drugs target some of these 
receptors (Kristiansen 2004).  GPCRs are characterized by seven transmembrane 
helices connected by three extracellular and three intracellular loops with an 
extracellular N-terminus and an intracellular C-terminus (Blenau and Baumann 2001, 
Kristiansen 2004, Farooqui 2007).  Upon receptor activation the receptor will activate 
a heterotrimeric G-protein that transmits the signal to a variety of effector proteins.  
This activation will increase or decrease the production of second messengers like 
cyclic adenosine monophosphate (cAMP), cyclic guanine monophosphate (cGMP), 
inositol phosphates, diacylglycerol, arachidonic acid, and inorganic ions.  These 
second messengers act upon second messenger proteins that will cause a variety of 
physiological events (Blenau and Baumann 2001, Kristiansen 2004, Farooqui 2007).  
GPCRs are utilized to a high degree in the pharmaceutical industry but have been 
under-utilized in the agrochemical industry thus providing a target to exploit for pest 
control.  In particular, the octopamine receptor is a preferential target, as this 
receptor is not found to a high degree in mammalian tissue. 
The original classification scheme for octopamine receptors was based on the 
effect various agonist and antagonists would have on whole tissue preparations 
(Evans 1981).  This classification scheme resulted in two classes of octopamine 
receptors; octopamine 1 and octopamine 2 (Figure 3a).  Octopamine 2 was sub-
classified into octopamine-2a, -2b, and later -2c, all three having different 
pharmacological features.  Octopamine-1 mediates its effects by activation of the 
inositol pathway leading to an increase in intracellular calcium.  The octopamine-2 
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receptors mediate their effects via activation of adenylyl cyclase leading to an 
increase in cAMP (Evans 1981, Evans and Maqueira 2005, Roeder 2005, Farooqui 
2007).   
The advent of molecular biology allowed for a new classification scheme for 
octopamine receptors as shown in Figure 3b.  This classification scheme was based 
on structural similarities of cloned receptors from Drosophila melanogaster and the 
vertebrate adrenergic receptors.  Octopamine-1 and octopamine-2 receptors were 
replaced with α-adrenergic-like and β-adrenergic-like octopamine receptors, 
respectively.  The α-adrenergic-like octopamine receptors showed high sequence 
similarity to the vertebrate α-adrenergic receptor, and the predominant second 
messenger was an increase in intracellular calcium.  Likewise, the β-adrenergic-like 
octopamine receptor shows a high sequence similarity to the mammalian β-
adrenergic receptors and causes an increase in cAMP.  Additionally, a third receptor 
type was added, the tyramine/octopamine receptor.  This receptor has the capability 
to bind both tyramine and octopamine and therefore displays agonist-specific 
coupling.  When tyramine is the agonist, it has an inhibitory effect on adenylyl 
cyclase leading to a decrease in cAMP.  When octopamine is the ligand, it generates  
an increase in intracellular calcium.    Despite the sequence similarities of 
octopamine receptors and adrenergic receptors, there are pharmacological 
differences, allowing octopamine to be an important target for insecticidal action 
(Evans et al. 1995, Evans and Maqueira 2005, Farooqui 2007).   
Octopamine receptors have been of particular interest in the development of 
new insecticides, since the receptors are only found at low levels in mammalian 
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tissue.  Several octopamine receptors have been isolated from various invertebrates 
(for a detailed list see Farooqui, 2007 and Roeder, 1999).  The success of finding 
compounds, either antagonists or agonists, has been limited.  The formamidine 
class, with chlordimeform as the lead compound, has been identified to be 
octopaminergic insecticides (Nathanson and Hunnicutt 1981, Gole et al. 1983, 
Davenport et al. 1985, Orr et al. 1990, Orr et al. 1992).  Shortly after formamidines a 
second class of chemicals, known as phenyliminoimidazolidines, emerged as being 
octopaminergic compounds (Nathanson 1985a, b).  Neither of these chemical 
classes has had significant success in the market place when compared to 
conventional insecticides. Essential oils have recently emerged as potential 
insecticidal compounds presumablly through their interaction with octopamine 
receptors (Enan 2001, Enan 2005b). 
Octopamine: Physiological significance 
Octopamine is an important neuroactive substance that has been shown to 
be involved in several physiological events that take place in the central nervous 
system and peripheral organs of invertebrates.  These physiological functions make 
octopamine an important neurotransmitter, neuromodulator, and neurohormone in 
various invertebrate tissues.  The effects of octopamine can be measured by 
monitoring responses when octopamine is applied to a tissue or by detection of 
altered phenotypes when octopamine is lacking (Roeder 1999, 2005).  D. 
melanogaster mutants were developed that did not synthesize octopamine, these 
mutants do not contain the tyramine-β-hydroxylase gene.  The phenotypic difference 
was sterility in female flies (Monastirioti et al. 1996).  RNAi (gene silencing) is just 
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starting to be used to determine the diverse physiological responses of octopamine 
(Farooqui et al. 2003).   
Octopamine released from DUM/VUM neurons has been shown to work 
closely with the muscles of peripheral appendages of invertebrates, particularly 
insects, where octopamine is important in maintaining correct orientation of the legs 
prior to, during, and after flight.  Octopamine is also important in increasing the 
power output of the insects’ wings during initial steps of flight (Roeder 1999, 2005).  
Octopamine has been shown to not only work on skeletal muscles but also on 
visceral muscles.  This is evident in the oviduct of the mutant Drosophila that have 
decreased levels of octopamine and therefore do not have the myogenic rhythm 
necessary to lay eggs (Monastirioti 2003).  Insect flight demands a significant 
amount of energy, and octopamine release increases insects’ myogenic rhythym of 
the dorsal heart and ventilation; both involve visceral muscles, providing cells with 
oxygen for energy production.  Octopamine is important in regulating endocrine 
gland activity by being involved in the release of hormones to perform many complex 
physiological functions (Roeder 1999, 2005). 
Octopaminergic cells can release octopamine into the hemolymph where it is 
carried to various peripheral targets.  The insect fat body is an important peripheral 
target in flying insects, because the insect switches from a carbohydrate source, 
trehalose, to a lipid source under highly demanding activities, such as flight or stress 
(Roeder 1999).  Octopamine targets hemocytes where it functions in the insects’ 
innate immune system by increasing phagocytosis, nodule formation, and clearance 
rate of microorganisms (Baines and Downer 1994).  Octopamine modulates 
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hemocytes by increasing hemocytes ability to engulf invading organisms (Dunphy 
and Downer 1994).  Octopamine’s true neurotransmitter effects are evident when 
looking at the firefly’s (Lampyridae) light organ where octopamine acts on neurons 
that innervate this organ (Roeder 1999, 2005).  Octopamine has also been shown to 
be involved in modulation of the insects’ sensory system, including acoustic, visual, 
olfactory, tactile, gustatory, and proprioception (Roeder 1999, 2005, Farooqui 2007).  
Octopamine has also been described to be involved in learning and memory.  This is 
particularly evident in social insects were octopamine is involved in the recognition of 
kin.  It has also been demonstrated that octopamine is important in controlling 
rhythmic neural behaviors like walking, flight, and digging (Roeder 1999, 2005). 
Yeast: An expression system for G-protein coupled receptors 
As previously mentioned G-protein-coupled receptors (GPCRs) are 
membrane-bound receptors that mediate communication across the membrane to 
elicit a physiological response.  These receptors have been highly conserved 
throughout evolution and are found in single-celled eukaryotic organisms, such as 
Saccharomyces cerevisiae (yeast).  Yeast cells have been used as a tool to study 
heterologously expressed GPCRs with the expression of multiple mammalian 
GPCRs (Minic et al. 2005) and invertebrate GPCRs (Kimber et al. 2009, Taman and 
Ribeiro 2009).  Yeast have also been used to study other membrane proteins like 
tyrosine kinases (Superti-Furga et al. 1996) and ion channels (Goldstein et al. 1996, 
Hahnenberger et al. 1996, Hahnenberger and Kurtz 1997).  The study of GPCRs 
and the pheromone response pathway in yeast is well established in the literature, 
and the information presented here is drawn from several reviews (Bardwell et al. 
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1994, Schwartz and Madhani 2004, Bardwell 2005, Ladds et al. 2005, Minic et al. 
2005, Slessareva and Dohlman 2006).   
S. cerevisiae are yeast cells that are commonly known as baker’s, brewer’s, 
or budding yeast, a named derived from their mode of cell division.  These yeast 
cells have two endogenous GPCRs, a pheromone mating receptor and a glucose-
sensing receptor.  Yeast cells are eukaryotic, and they have the capability to perform 
the necessary post-translational modifications to create an active GPCR.  Yeast 
cells can be genetically manipulated to create engineered cell lines for expression of 
heterologous proteins.  Yeast also expresses two endogenous GPCRs that are not 
found in mammalian cells, decreasing the possibility for a competing receptor.  A 
variety of reporter systems have been developed that allow receptor activation to be 
quantified (e.g. linked to the pheromone pathway, as described below).  Finally, the 
cells rapidly grow to a high density on medium that is relatively inexpensive.  
However, there are some drawbacks to using yeast to heterologously express 
GPCRs.  While the cells are capable of some post-translational modifications to 
achieve a functional receptor, not all modifications can be successfully performed, 
leaving some receptors inactive or unable to be expressed at the cell membrane.  
There can be complications with coupling the expressed receptor to the endogenous 
heterotrimeric G-protein.  Finally, the thick yeast cell wall can inhibit some ligands 
from binding appropriately and prevent the activation of the receptor (Bardwell et al. 
1994, Bardwell 2005). 
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Yeast growth: The pheromone mating pathway 
The mating process of S. cerevisiae is characterized by the release of two 
types of mating peptides referred to as pheromones.  These pheromones bind to 
GPCRs, and that starts the mating process.  Yeast cells that release a 13-peptide 
(α-pheromone) are referred to as α-cells (Mat-α), and cells that release a 12-peptide 
(a-pheromone) are referred to as a-cells (Mat-a). Mat-α or Mat-a will express a 
GPCR that is capable of binding the pheromone that they do not release.  Once two 
opposite haploid yeast cells bind their appropriate pheromone and activate their 
receptor, a cascade of biochemical and physiological events are initiated to create a 
diploid cell.  Some of the changes include expression of different genes, cell cycle 
arrest, morphological changes of the cell, and fusion of the cellular membranes and 
the exchange of genetic information.  This pathway was discovered with sterile 
mutants: therefore multiple genes are referred to as Ste. Common genes and their 
respective proteins in this pathway are listed in Table 2. 
Biochemical activity of the pheromone pathway 
The biochemical events of the pheromone pathway are illustrated in Figure 4, 
while modifications to this pathway, to functionally express an exogenous GPCR are 
illustrated in Figure 5.  The two cell types, Mat-a or Mat-α, will express an STE2 or 
STE3 receptor, respectively, which are involved in the binding of their conjugate 
pheromone.  Activation of these receptors leads to the recruitment and activation of 
a heterotrimeric G-protein, which is similar to the process seen in insects and 
mammals.  The heterotrimeric G-protein is derived from three genes: gpa1 (Gα), ste4 
(Gβ), and ste18 (Gγ).  Upon receptor activation (pheromone stimulation) the Gα 
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subunit will replace GDP with GTP and dissociate from the other subunits, creating a 
Gβγ dimer.  Signal transduction, with regard to the pheromone response pathway, is 
performed by the Gβγ dimer, which is attached to the membrane by farnesyl and 
palmitoyl groups via Gγ.  Gβγ has three important interactions: first, Gβγ interacts with 
STE20, which is already associated with and activated by CDC42, allowing this 
STE20 to phosphorylate targets.  The second interaction of the Gβγ dimer is the 
recruitment of STE5, a scaffold protein that localizes crucial proteins and assists in 
their activation during signal transduction (mitogen-activated protein kinase (MAPK) 
pathway).  The third interaction of the Gβγ dimer is with Far 1.  Gβγ dimer will bind to 
a FAR1/CDC24 complex resulting in cell cycle arrest at the G1 phase (Bardwell 
2005, Ladds et al. 2005, Minic et al. 2005). 
The MAPKs are serine/threonine protein kinases that are involved in various 
cellular functions (gene expression, cell division, cell proliferation, and cell survival).  
This kinase pathway plays a pivotal role in the yeast pheromone system by 
modifying the expression of approximately 200 genes.  The four important gene 
products in this pathway are (1) MEKK (mitogen-activated protein kinase kinase 
kinase; ste11), (2) MEK (mitogen-activated protein kinase kinase; ste7), and there 
are two MAPKs; (3) fus3 and (4) kss1.   STE5, the scaffold protein, serves as a 
platform for all of the proteins involved in the MAPK pathway.  The cascade is 
initiated when STE5 binds to Gβγ localizing this at the plasma membrane in close 
proximity to STE20/CDC42 complex.  TheSTE20/CDC42 complex phosphorylates 
STE11 (MEKK), and in return, STE11 is thought to phosphorylate STE7 (MEK), and 
STE7 will ultimately phosphorylate the two MAPKs (FUS3 and KSS1).  FUS3 and 
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KSS1 are transcriptional factors that activate genes involved in cellular growth.  In 
particular they act on genes ste12, dig1, dig2, and far1.  With respect to the yeast 
pheromone pathway, STE12 is of particular importance as it binds to pheromone-
responsive elements to regulate gene expression.  A common gene regulated by 
pheromone-response elements is fus1 (usually linked to reporters).  DIG1 and DIG2 
decrease the activity of STE12 by acting as regulators.  FUS3 is also involved in 
phosphorylating FAR1, which works closely with CDC24, and allows the cell to enter 
cell cycle arrest and prepare to grow towards its mating partner.  This ultimately 
allows the two cells to fuse together and exchange nuclear information to create a 
single diploid cell (Schwartz and Madhani 2004, Bardwell 2005). 
Once this pathway has been activated there are multiple regulatory 
mechanisms to control or terminate the signal.  A common way to regulate the 
pheromone pathway is with the gene sst2.  SST2 is a regulator of G-protein 
signaling (RGS) and increases the hydrolysis of GTP to form GDP in the Gα-subunit, 
resulting in an inactive G protein.  Beside SST2, multiple negative regulators of 
pheromone receptor activation and signal transduction have been discovered.  
These include the ability of the yeast cell to produce proteases that degrade the 
pheromone.  The cell has the ability to phosphorylate the pheromone-bound 
receptor, which desensitizes the receptor and also tags the receptor for endocytosis.  
These regulatory mechanisms are important to consider when modifying these cells 
to have growth as a quantitative measure of expressed receptors (Bardwell 2005).  
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Modifications to yeast cells to successfully express heterologous receptors 
The expression of heterologous GPCRs in yeast has been accomplished for 
multiple receptor types (Minic et al. 2005, Kimber et al. 2009, Taman and Ribeiro 
2009).  However, not all receptors are expressed efficiently.  The receptor may not 
be expressed at the cell wall because it is held in intracellular compartments and 
potentially degraded.  There may be improper linking of the expressed receptor to 
the endogenous heterotrimeric G-protein leading to increased constitutive activity.    
Some receptors have been expressed using the yeast signaling machinery (Price et 
al. 1995, Price et al. 1996).  Sometimes modifications to the expressed receptor may 
be necessary (Payette et al. 1990).  Modifications to the G-protein have also 
increased the ability of the expressed receptor to properly signal in yeast cells.  A 
series of Gα chimeras have been developed where modifications to the C-terminus 
of the yeast’s Gα (gpa1) subunit have been replaced with the C-terminus of various 
mammalian subunits.  This creation allows Gα to interact with the expressed receptor 
but still have affinity for the endogenous Gβγ subunits (Ladds et al. 2005, Minic et al. 
2005).   
A benefit of utilizing yeast to express GPCRs is the availability of reporters 
from engineered cell lines.  The fus1 gene is widely used to link reporter genes 
because of its low basal activity.  Since fus1 is at the end of the pheromone mating 
pathway, the output for an assay is usually based on growth.  A fus1-his3 construct 
allows the engineered cell to grow in medium lacking the amino acid histidine, which 
is vital for protein synthesis and normal cellular activities.  When cells are activated 
by a ligand (agonist) this leads to the synthesis of histidine, and therefore allowing 
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cells to undergo normal protein synthesis.  A fus1-hph reporter allows yeast cells 
that are stimulated by a ligand to grow in the presence of the antibiotic hygromycin.  
This is due to the hph gene encoding hygromycin phosphotransferase, a gene for 
detoxifying  hygromycin.  Yeast strains with a mutated can1 gene are able to grow in 
the presence of the toxic arginine analogue canavanine.  However, stimulation of a 
pheromone response system that has a fus1-can1 construct decreases the viability 
of the yeast cells allowing an antagonist being screened to stop the production of the 
CAN1 protein, and thus the encoding of an arganine permease.  A fus1-lacZ 
construct is available that allows for quantitative measurements based on β-
galactosidase activity.  This is available in a colorimetric and fluorometric assay.  
The last common reporter available is a fus1-luc cell where activation of the 
pheromone pathway results in the production of luciferase, a bioluminescence 
enzyme that allows for easy detection and quantification.  
Summary 
Insects can have a significant economic impact to agriculture and public 
heath because of their ability to transmit viruses and other pathogens.  Wide use of 
some insecticides has increase resistance amongst insects and therefore new and 
safe alternative are needed to control insect pests (Tsao and Coats 1995, Isman 
2000, Isman 2006).  Plants have evolved specialized mechanisms that interact with 
insects, which may cause behavioral changes or deleterious physiological effects 
like chemical toxicity.  These mechanisms may be initiated by the plants’ synthesis 
and release of essential oils.  Essential oils are complex mixtures of 
monoterpenoids, sesquiterpenoids, and related aromatic compounds.  The large 
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variety of chemistries present in essential oils leads to the possibility that alternative, 
more rational insect control measures can be found. This is important as public 
concern about the toxicity of conventional insecticides is growing.  Octopamine is a 
vital neuroactive substance in insects, and its receptors may serve as a preferential 
target for insecticides as it does not share this physiological importance in mammals.  
I have expressed a previously identified octopamine receptor from the American 
cockroach (Periplaneta americana) in the yeast, Saccharomyces cerevisiae.  Yeast 
have emerged as a vital tool for high-throughput analysis in the pharmaceutical 
industry.  Yeast are eukaryotic single-celled organisms that have the capability of 
performing post-translational modifications, thereby expressing a functional receptor.  
This capability is being utilized to screen naturally occurring compounds from plant 
essential oils to determine their efficacy at this isolated octopamine receptor.  
Role of Co-Authors 
Dr. Joel Coats served as the primary PI for the research presented in this 
thesis.  Additional advising and support for the progression of the research was 
performed by Dr. Michael Kimber as his expertise in heterologous expression and 
molecular biology was vital to the research presented in this thesis.  Dr. Tim Day 
provided additional support during data collection and equipment needs.  Dr. Paula 
Riberio acted as a collaborator for yeast expression and the provider of the 
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Figure 1A.  Structure of an Isoprene unit.  Isoprene units are the 5-carbon 
building blocks of monoterpenoids and sesquiterpenoids 
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Figure 1B.  Coupling of isoprene units.  Isoprene units can couple by head-to-tail, 
head-to-head, and head-to-middle fusions.  These fusions result in the basic 
skeleton backbone that can lead to a wide variety of monoterpenoid compounds 
 
 
 
 
 
 
 Figure 2.  Biosynthesis of terpenoids.  
sesquiterpenoids is shown.  Isopentenyl pyrophosphate (IPP) and dimethyl
pyrophosphate (DMAPP, an isomer of IPP) fuse together resulting in geranyl 
diphosphate.  Geranyl diphosphate is the carbon skeleton of monoterpenoids.  
Addition of a second IPP group results in the loss of a two phosphate groups and the 
production of farnesyl diphosphate, which is the carbon skeleton for 
sesquiterpenoids.  Each of the carbon skeletons are further targeted by certain 
enzymes resulting in cyclization and addition of functional groups (adapted from 
Croteau et al. 2000). 
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The biosynthesis of monoterpenoids and 
 
allyl 
Figure 3a.  Original classification of octopamine receptors
based on whole tissue responses to agonists and antagonists.
 
Figure 3b.  New classification of octopamine receptors.  
receptor classification based on sequence similarities between 
melanogaster and mammalian adrenergic receptors.  Receptors were sub
based on affinities for agonists or antagonists.
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Figure 4.  Pheromone response pathway.
through a mating pathway, which is diagramed below.
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Figure 5.  Engineered pheromone response pathway.  
expression some genes are removed or manipulate
below. 
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Table 1.  Terpenoid classes.  The major classes of terpenoids are composed of 
various number of isoprene units, as indicated, each isoprene allows for the addition 
of 5 carbons.  
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Gene/protein name Definition of the name 
Ste Sterile 
Gpa G-protein α-subunit 
Cdc Cell division control 
Fus Fusion 
Far Factor arrest 
Sst Supersensitive, referring to sensitivity to pheromone 
Kss Kinase suppressor of Sst 
Dig Down-regulator of invasive growth 
 
Table 2.  Gene and protein names for yeast pheromone pathway.  Gene and 
protein names that are related to the pheromone response pathway in yeast mating 
(adapted from Bardwell, 2005). 
 
  
37 
 
CHAPTER 2. High through-put screening of plant essential oil 
constituents against a ligand-independent α-adrenergic-like 
octopamine receptor from Periplaneta americana 
 
An article for submission to Pesticide Biochemistry and Physiology 
 
Aaron D. Gross, Michael J. Kimber, Tim A. Day, Paula Riberio, and Joel R. Coats 
Abstract 
Octopamine, an important biogenic monoamine, is found in multiple 
invertebrates, including insects, where it functions as a neurotransmitter, 
neuromodulator, and a neurohormone.  Octopamine activates G-protein-coupled 
receptors (GPCRs), which can activate or inhibit various signal transduction 
pathways.  Essential oils are produced by plants and have been shown to have 
repellent, attractant, and insecticidal properties.  It is presumed that these effects are 
produced through their interaction with octopamine receptors.  Here we have 
developed a ligand-independent high-throughput screening system for the α-
adrenergic-like octopamine receptor from Periplaneta americana (Pa oa1) and 
expressed this receptor in the yeast, Saccharomyces cerevisiae.  We determined 
that a variety of monoterpneoids and related aromatic compounds interact with Pa 
oa1.  This interaction indicates that most of these compounds act as inverse 
agonists to a constitutively active receptor.  However, we report that the aromatic 
compound carvacrol acts as a positive modulator at Pa oa1. 
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Introduction 
Increased public concern about the safety of synthetic insecticides has led to 
increased governmental restrictions on the availability and use of some conventional 
insecticides and acaricides through the Food Quality Protection Act of 1996.  These 
restrictions, along with resistance of arthropod pests, due to over use or improper 
use, are leaving an opportunity in the market place for new safe and effective 
insecticides to control important pests in both agriculture and public health [1, 2]. 
Throughout evolution, plants have developed methods to resist microbial 
attack and herbivoral feeding.  Protection routes include the plant’s ability to produce 
an essential oil, which is the strong odiferous lipophillic liquid that is obtained by 
steam distillation of plant material.  Essential oils are used in everyday applications 
such as flavors and preservatives for food, products in the cosmetic and fragrance 
industries, aromatherapy, in household cleaning products, and in some 
pharmaceutical products.  Exposure to these oils, and their individual constituents, 
are routinely encountered in our diet and personal care products, some oils are on 
the United State Environmental Protection Agency’s 25b exempt list, and some are 
listed by the United States Food and Drug Administration as Generally Recognized 
As Safe (GRAS).  Essential oils are composed of various terpenes/terpenoids and 
aromatic compounds; here “terpene” and “terpenoid” will be used interchangeably.  
Terpenoids are biosynthesized from isoprene units, which are 5-carbon building 
blocks.  Coupling of isoprene units can lead to 10-carbon structures known as 
monoterpenoids.  These isoprene backbones are targeted by endogenous plant 
enzymes to create various functional groups and/or bicyclic structures [3-5].  
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Aromatic compounds are also found in these oils but to a lesser degree than 
terpenoids [4].  Essential oils, and their constituents, have previously been 
investigated for their toxicity [6-8], and it has been suggested that they exert this 
toxic effect through a neurological mechanism.  Several neurological sites have 
been investigated including: acetylcholinesterase [9-14], GABA receptors [15], 
octopamine receptors [16-19], and tyramine receptors [20, 21]. 
Octopamine, an important biogenic monoamine in invertebrates, has 
significant physiological actions in insects [22-25].  Octopamine exerts these 
physiological actions through the superfamily of G protein-coupled receptors 
(GPCRs) [26].  The original classification of these receptors was based on tissue 
response to agonists or antagonists and resulted in octopamine-1 and octopamine-2 
receptors, the latter being subclassified into octopamine-2a, -2b, and -2c receptors.  
The octopamine-1 receptors led to an increase in intracellular calcium while 
octopamine-2 receptors increase intracellular cAMP.  A new classification of 
octopamine receptors is available and is based on sequence similarity between 
Drosophila melanogaster octopamine receptors and the mammalian adrenergic 
receptors.  This has resulted in “octopamine-1” receptors being re-classified as α-
adrenergic-like octopamine receptors, and octopamine-2 receptors being re-
classified as β-adrenergic-like octopamine receptors (still subclassified); the signal 
transduction pathways remain the same.  Another class of receptor was found, 
named the tyramine/octopamine receptor that binds both ligands but displays ligand-
dependent signaling activity.  Therefore, when tyramine is the ligand the receptor 
has an inhibitory effect on cAMP levels, and when octopamine is present an 
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increase cellular concentrations of calcium is observed [27].  Octopamine receptors 
have been identified as the site of action of the formamidine class of insecticides 
[28-33]. 
GPCRs have been studied for their possible involvement in human disease 
and as targets for pharmaceutical intervention.  It is estimated that 30-45% of current 
pharmaceuticals target these receptors [34].  Saccharomyces cerevisiae, referred to 
as yeast hereafter, has emerged as an important organism for the study of 
heterologously expressed GPCRs [35, 36].  Functional expression of heterotrimeric 
GPCRs can be achieved by linking the expressed receptor to the endogenous 
pheromone response pathway, which has been performed for analysis of multiple 
mammalian GPCRs [36] and some invertebrate GPCRs [37, 38].    
The present study aimed to (1) isolate a previously identified octopamine 
receptor from the brain of Peripleneta americana (Pa oa1); (2) functionally express 
Pa oa1 in the yeast S. cerevisiae; (3) utilize the yeast expressing Pa oa1 to screen 
monoterpenoids and related aromatic compounds from plant essential oils to 
determine their ability to interact with this receptor. 
Materials and Methods 
Insects 
American cockroaches (P. americana) were maintained in an established 
colony under a 14:10 light:dark photocycle period at 23 ± 2°C.  These insects were 
provided with an unlimited supply of ground cat food and water.   
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Chemicals 
All monoterpenoids and aromatic compounds were purchased from Sigma 
(St. Louis, MO) with the exception of pulegone, which was purchased from Eastman 
Chemical Company (Miami, FL).  For screening purposes the compounds were 
dissolved in dimethyl sulfoxide (DMSO) and serial diluted to 1 x 10-4 M.  The final 
concentration of DMSO to which the cells were exposed was less than 1%.  
Isolation of the American cockroach octopamine receptor 1 (Pa oa1) 
Brain tissue was obtained from both male and female American cockroaches 
and homogenized with a mortar and pestle, and RNA was extracted using TRI 
Reagent (Sigma).  DNA was degraded using a TURBO DNA-free® kit (Applied 
Biosystems/Ambion; Foster City, CA).  Complementary DNA (cDNA) was prepared 
with gene-specific primers developed for the sense strand (5`-ATGAGGGACGGGG-
TTATGG-AAC-3`) and the antisense strand (5`CTACCTAGCCTGAGG- TCCACT3`).  
Primers were developed based on the sequence of a P. americana octopamine 
receptor 1 (Pa oa1) previously reported [39].  Cloning of the octopamine receptor’s 
open reading frame was performed using SuperScript® III one-step RT-PCR with 
Platiun® Taq DNA Polymerase (Invitrogen: Carlsbad, CA).  PCR reactions were 
performed with a Thermo Hybaid Px2 thermal cycler and visualized on a 1.2% 
agarose gel containing ethidium bromide.  Amplicons were extracted from the gel 
using a PureLink Gel Extraction Kit (Invitrogen).  The open reading frame was 
ligated into the pGEM-T Easy Vector system (Promega; Madison, WI), which was 
transformed into competent JM109 Escherichia coli cells (Promega).  Plasmid DNA 
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was isolated using Wizard® Plus SV minipreps DNA Purification System (Promega) 
for sequence analysis.  DNA sequence was aligned using Vector NTI v10.0 Software 
(Invitrogen) and compared to the previously identified octopamine receptor [39].   
Functional expression of Pa oa1 in yeast 
The receptor open reading frame was PCR-amplified using primers that 
added an NcoI site (5`GCCATACCATGGGGGACGGGGTTATGAACGCTA3`) and 
an XbaI site (5`GCCATATCTAGATCACCTGGAGTCCGATCCATCGTTG3`) at the 
5` and 3` ends, respectively.  PCR reactions were performed with a Thermo Hybaid 
Px2 thermal cycler using High-fidelity Taq polymerase (Invitrogen).  Purified 
amplicons were ligated into a linearized yeast expression vector, Cp4258, and then 
transformed into competent Jm109 E. coli cells.  Individual colonies were PCR 
checked, using gene-specific primers, for the presence of the receptor and cultured 
overnight in LB medium supplemented with ampicillin (30°C, 150 RPM).  Plasmid 
DNA was isolated using the HiSpeed plasmid Midi Kit (QIAGEN; Germantown, MD) 
and underwent sequence analysis to confirm receptor orientation and fidelity. 
A variety of genetically engineered yeast cell lines were obtained (kindly 
provided by J. Broach, Princeton University) that differed in their expression of the 
G-protein α-subunit (Table 1).  Transformation of the cell lines occurred by using a 
lithium acetate method [40].  Briefly, yeast cells are grown in YPD medium (Sigma) 
to mid-log phase at 30°C and 250 RPM.  Cells were pe lleted (4,000 x g, 5 min, room 
temperature) and washed with sterile water and resuspended in 10 mL of lithium 
acetate solution (1 mL of 10 X lithium acetate (10 mM), 1 mL of10X Tris-EDTA (TE) 
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buffer (0.01M Tris-HCl, 400µM EDTA, pH 7.5), and 8 mL of sterile water); this 
solution was incubated on an orbital shaker for 1 hr at 30°C and 250 RPM.  
Transformation of the engineered cell lines (Table 1) was performed by adding 200 
µL of yeast/lithium acetate suspension, 200 µg of UltraPureTM Salmon Sperm DNA 
(Invitrogen) and 1 µg of vector carrying receptor or 1 µg of empty vector (mock cells) 
in 1.2 mL of lithium acetate PEG solution (1 mL of 10 TE, 1 mL of 10 LiAc, 8 mL of 
50% PEG4000).  Transformants were selected on leucine-deficient medium (1 x 
YNB (Difco: Houston, TX), 1 x yeast synthetic dropout supplemented with leucine 
(Sigma), 10 mM ammonium sulfate (Sigma), 2% glucose (Sigma)).  The presence of 
the octopamine receptor gene was achieved by yeast DNA extraction using a “bust 
n’ grab”  method and PCR amplification with gene-specific primers [41].  Once 
positive colonies were identified, the yeast cells were maintained in selective 
medium (-Leu) supplemented with octopamine.  Yeast cells were stored at -80°C in 
15% glycerol stocks. 
Yeast membrane preparations for radioligand binding experiments. 
A functional octopamine receptor was confirmed by using radioligand binding 
and yeast membrane preparations [42].  Yeast cells were grown in medium deficient 
in leucine overnight at 30°C and 250 RPM.  Cells were  centrifuged at 1,500 x g for 
10 min at room temperature and resuspended in 10 mL of homogenization buffer 
(1mM sodium bicarbonate, 1mM EDTA, 1mM EGTA, pH 7.4) along with 1 tablet of 
protease inhibitor cocktail tablet (Roche Applied Science; Indianapolis, IN).  Glass 
beads were added (Sigma 425-600 µm) at twice the wet weight of the yeast pellet.  
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The yeast homogenate sample was maintained on ice prior to and between 
vortexing.  Yeast homogenates were obtained by vortexing for 1 min at top speed 
and cooling the suspension for 2 min; this was repeated three times.  Cell debris and 
beads were centrifuged at 1,500 x g for 10 minutes.  The supernatant was separated 
and replaced with 10 mL of homogenization buffer, and these steps were repeated 
without addition of protease inhibitors.  Supernatants collected were centrifuged at 
23,000 x g for 20 min at 4°C, the pellet was washed, and centrifugation repeated.  
Protein aliquots were prepared, and protein concentration was determined using a 
Total Protein Kit, Micro Lowry, Peterson’s Modification (Sigma). 
Radiolabed binding experiments with recombinant membrane preparations 
Binding experiments were performed with 50 µg of protein in binding buffer 
(50 mM Tris-HCl, 5 mM magnesium chloride, 2 mM ascorbic acid, pH 7.4), the 
radioligand [3H]-octopamine (American Radiolabeled Chemicals Inc. St. Louis, MO), 
and vehicle/test solution at a final volume of 200 µL.  The reaction was initiated with 
radioligand and incubated at room temperature for 1 hr (shaking 300 RPM).  
Reactions were filtered through Whatman GF/C glass fiber filters (Sigma), which 
were pre-rinsed with 2 mL of assay buffer.  The filters were washed in 10 mL of cold 
assay buffer at 300 RPM for 15 minutes at room temperature.  Filters were dried and 
placed in 15 mL of Ultima GoldTM scintillation solution (PerkinElmer; Waltham, MA) 
and counted using a Beckmann LS 5000CE.  
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Histidine auxotrophic assay 
The histidine-auxotrophic assay was performed similarly to the method of 
Kimber et al. (2009).  Briefly, 2 mL of selective medium (-Leu) was inoculated with 
transformed yeast cells (frozen glycerol stocks) and allowed to grow overnight on an 
orbital shaker (30°C and 250 RPM (OD 600 1.0-2.0)).  Cells were pelleted at 5,000 x g 
at room temperature and washed three times with medium deficient in leucine and 
histidine (1x yeast nitrogen base (Difco), 1x yeast synthetic dropout medium 
supplement without leucine, tryptophan, uracil, and histidine (Sigma), 170 mM uracil 
(Sigma),   93 mM L-tryptophan (Sigma), 10 mM ammonium sulfate (Sigma), 2% 
glucose (Sigma), 50 mM 4-morpholinepropanesulfonic acid (MOPS; Sigma), pH 
6.8).  The pellet was finally resuspended in 1 mL of leucine/histidine deficient media 
supplemented with 10 mM 3-amino-1,2,4-triazole (3-AT;Sigma) to help control 
growth.  Cells were dispensed into a 96-well clear Costar® plate with a total volume 
of 200 µL at 15-20 cells/µL (OD600 of 0.01), which included 10 µL of vehicle or test 
compound solution.  Cells were allowed to grow at 30°C and 98% humidity for 24 hr 
at which time optical density readings (absorbance of 600 nm) were taken using a 
Spectramax 190 (Molecular Devices, Inc. Sunnyvale, CA).  Experiments were 
performed in quadruplicate on 96-well plates for one experiment, with a total of five 
experiments performed for statistical analysis. 
Statistical analysis for yeast growth experiments was performed using SAS 
9.2 (DAS Institute Inc, Cary, NC).  Data from growth experiments was normalized 
relative to the control (vehicle only), and data was subjected to analysis of variance 
(ANOVA); log transformations were performed to achieve a best-fit model.  
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Statistical analysis for binding experiments was performed with Prizm 5.0 (GraphPad 
Software, San Diego, CA).    
Results  
Isolation of receptor 
The α-adrenergic-like octopamine receptor from P. americana (Pa oa1) was 
isolated using gene-specific primers.  The full-length receptor was obtained by 
performing RT-PCR on tissue obtained from male and female American cockroach 
brains.  Pa oa1 protein was compared to other protein sequences by performing a 
BLASTp search (www.blast.ncbi.nlm.nih.gov).  Protein sequence similarities have 
been made between this octopamine receptor and receptors from D. melanogaster 
(OAMB) and Lymnaea stagnalis (Lym oa1) [39].  However, the availability of more 
sequence data indicates high sequence similarity to Apis mellifera [43] and Bombyx 
mori [44].  Putative octopamine receptors fragments were also identified from a 
variety of invertebrate species including Anopheles gambiae, Ixodes scapularis, and 
Tribolium castaneum. 
Expression of Pa oa1 in the yeast S. cerevisiae 
Expression of the isolated octopamine gene was performed using a lithium 
acetate method [40].  The presence of the octopamine receptor open reading frame 
was confirmed by performing PCR with gene-specific primers.  The amplicon is 
approximately 2 kb; Pa oa1 cDNA size is known to be 1.9 kb (Figure 3) [39].  To 
confirm the presence of a functional receptor radioligand, binding with 3H-
octopamine was performed in increasing concentrations of un-labeled octopamine.  
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A concentration-dependent decrease in radioligand binding was observed with 
increased concentrations of un-labeled octopamine, as shown in Figure 4.  This 
result indicates the presence of a functional receptor expressed at the plasma 
membrane and shows the ability of the receptor to bind octopamine. 
The isolated American cockroach octopamine receptor was expressed in a 
variety of genetically modified yeast cells (Table 1).  Each cell line was transformed 
with Pa oa1 to find a cell line suitable to perform a histidine-auxotrophic assay.  In 
this assay the heterologous receptor (Pa oa1) is linked to the endogenous yeast 
pheromone pathway.  Activation of this pathway results in the expression a fus-1 
promoter gene leading to the activation of a his3 reporter gene allowing the 
production of histidine.  Therefore, cells that are present in histidine-deficient 
medium cannot perform the protein synthesis necessary for growth unless histidine 
is added to the medium or histidine synthesis is induced [37, 38, 45]. 
Transformation of the engineered yeast cell line CY18043 with Pa oa1 
effectively coupled to the heterotrimeric G-protein, with a chimeric Gαq.  However, 
when Pa oa1 was expressed in CY18043 it displayed ligand-independent activity 
(constitutive activity) leading to continuous growth with or without the previously 
identified ligand, octopamine (Figure 5).  This receptor also did not respond to 
octopamine’s immediate synthetic precursor tyramine (Figure 5).  This significant 
increase in growth, when compared to cells transformed with an empty vector, was 
approximately 35-fold.  When Pa oa1 was expressed in other engineered yeast cell 
lines (Table 1), the degree of increased growth was not significant and generally less 
than 5-fold (data not shown).  The lack of response to octopamine or tyramine led us 
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to hypothesize that the receptor was constitutive and in the activated state, 
assuming a two-state receptor model [34].  Namely the heterotrimeric G-protein was 
dissociated into the Gα-GTP and Gβγ dimer, allowing the cell to enter the pheromone 
stimulation pathway and allowing activation of the reporter gene his3; leading to 
synthesis of histidine and thereby an increase in cellular growth.  To test this 
hypothesis, compounds were screened to determine if they could bind to the 
receptor and slow growth, acting as inverse agonists or bind and cause increased 
growth, acting as a potential positive allosteric modulator.   
Phentolamine, a previously identified antagonist of Pa oa1 [39], was added to 
constitutively active yeast cells, and it decreased yeast cell growth significantly to 63 
± 2% (p-value < 0.001) when compared to the vehicle control (Figure 6).  
Synephrine, a methylated analogue of octopamine has been shown to increase 
cAMP production in P. americana hemocytes [46] but has also been shown to have 
an inhibitory effect on forskolin-stimulated cAMP production in a heterologously 
expressed D. melanogaster octopamine/tyramine receptor [47].  Synephrine 
decreased yeast growth significantly to 48 ± 3% when compared to the control (p-
value < 0.001) as shown in Figure 6.  Finally, chlordimeform, a formamidine 
insecticide, was added to yeast expressing Pa oa1 and had an inhibitory effect on 
growth, decreasing it significantly to 73 ± 5% (p-value < 0.001) of the control (Figure 
6).  Therefore, phentolamine, synephrine, and chlordimeform all had an inhibitory 
effect on the expressed Pa oa1 receptor, thereby, decreasing the growth of these 
yeast cells. 
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The ability of our assay to show binding of compounds and display an 
inhibitory growth effect on growth or yeast cells expressing Pa oa1 led to the next 
hypothesis that some monoterpenoids or aromatic compounds can bind to and alter 
Pa oa1, thereby indirectly affecting growth of these yeast cells.  To test this 
hypothesis, several monoterpenoids were screened against the yeast cells, and their 
growth effects are shown in Figure 7 and Table 2.  Several compounds did not have 
a statistically significant effect on growth and therefore were assumed to have no 
effect on Pa oa1.  These compounds include α-pinene, limonene oxide, α-terpineol, 
linalool, 1,8-cineole, and menthol (p-value >0.05).  However, several 
monoterpenoids did have a significant effect on the growth of the cells.  The effect of 
monoterpenoids on the constitutively active Pa oa1 expressing yeast cells, can be 
characterized as inverse agonists.  These compounds include1,4-cineole (p-value 
0.01-0.001), citronellic acid (p-value 0.01-0.001), pulegone (p-value <0.001), 
limonene (p-value <0.001), and camphor (p-value <0.001) (Figure 7 and Table 2).   
Aromatic compounds were also screened to see if they would bind to Pa oa1 
and thereby alter the growth of the yeast cells.  The aromatic compounds thymol and 
methyl salicylate had no significant activity when compared to the control (vehicle or 
ligand-independent activity), as shown in Figure 8 and Table 3.  The aromatic 
compound carvacrol had a stimulatory effect on growth, thereby significantly 
increasing growth to 130 + 7% (p-value <0.001) when compared to the control.  This 
was the only compound that significantly increased growth (Figure 8 and Table 3).  
Other aromatic compounds, like the monoterpenoids, had an inhibitory effect on the 
Pa oa1 (as inverse agonists) thereby leading to a decrease in growth (Figure 8 and 
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Table 3).  The aromatic compounds that displayed this activity include saffrole (p-
value 0.01-0.05), cymene (p-value 0.01-0.001), phenethyl propionate (p-value < 
0.001), cinnamic acid (p-value < 0.001), piperonal (p-value < 0.001), vanillin (p-value 
< 0.001), eugenol (p-value < 0.001), and methyl eugenol (p-value < 0.001); this data 
is shown in Figure 8 and Table 3.  A comparison of effects of monoterpenoids and 
related aromatic compounds have on octopamine receptors is shown in Table 4 and 
Table 5, respectively.  This comparison was made based on radioligand binding 
from a previous study using American cockroach tissue [16] and one studying the 
electrophysiology of the unpaired ventral nerve cords [19]. The most notable 
difference seen between our screening and other screening is that compounds that 
were previously identified as antagonists have been re-classified, in our assay, as 
inverse agonists. 
Discussion 
Some natural products, such as essential oils and their constituents, have 
toxic effects to insects.  The symptoms of their toxic action have suggested a 
neurological mode of action [6-8] resulting in numerous studies investigating 
different potential neurological sites of action [10-16].  Octopamine receptors have 
emerged as a preferential target for insecticide action as they do not have a 
significant function in mammalian tissue, decreasing the likelihood of mammalian 
toxicity.  Here we report that constituents of essential oils, primarily monoterpenoids 
and related aromatic compounds, have an effect at the octopamine receptor Pa oa1 
when expressed in S. cerevisisae.   
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We have demonstrated that one engineered yeast cell line expressing a Gαo 
chimeric G-protein exhibits high growth without the presence of the ligand, 
octopamine.  Therefore, when Pa oa1 is expressed in this cell line it demonstrates 
ligand-independent activity, i.e. the cells’ G-protein is constitutively in the active 
state.  It is assumed that the receptor is in the activated state because of the lack of 
response from the receptor to its previously identified ligand, octopamine (Figures 5 
and 6) [39].  Since the octopamine receptor is activated, a search was initiated to 
identify compounds that would bind to the receptor, resulting in changing of 
conformation of the receptor and inactivating the heterotrimeric G-protein, acting as 
inverse agonists.  A two-state receptor model may be too simplified to describe the 
multiple active conformations seen with GPCRs as we have demonstrated various 
degrees of efficacy.  Therefore, we would expect to see differences in receptor 
interactions based on physicochemical differences of the ligands (partial or full 
inverse agonist, but allosteric modulation is also a possibility).  
A variety of compounds that have been shown to interact with octopamine 
receptors were screened including synephrine, chlordimeform, and phentolamine 
(Figure 6).  Synephrine, the N-methylated analog of octopamine, has high affinity for 
octopamine receptors [46, 48].  However, synephrine decreases the amount of 
second messenger production by some receptors, as seen with an 
octopamine/tyramine receptor from D. melanogaster.  This receptor, when 
expressed in CHO-K1 cells, resulted in a significant increase in intracellular calcium 
when exposed to octopamine.  However, a decrease of forskolin-stimulated cAMP 
occurred on exposure of the receptor to octopamine, tyramine and synephrine [46].  
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When synephrine was screened against yeast cells in our assay, it interacted with 
Pa oa1 to significantly decrease growth (48 ± 3%).  Synephrine has not been 
previously investigated with Pa oa1 in a mammalian cell line to determine if it would 
affect second messenger production.  Therefore, we cannot conclusively state that 
synephrine would decrease second messenger production, but it does appear to 
have an inhibitory action on Pa oa1.  The formamidine insecticides, with 
chlordimeform as the lead compound, were octopaminergic compounds that have 
been shown to be toxic and only one is available in the United State today.   It is 
believed that the metabolite of chlordimeform (desmethyl chlordimeform) was potent 
at octopamine receptors [33].  However, chlordimeform was shown to cause a 
nonselective decrease in adenylate cyclase activity and therefore was not 
dependent on the interaction with an octopamine receptor [33].  Here we show 
chlordimeform acts as a partial inverse agonist at Pa oa1, decreasing growth to 73 ± 
5% when compared to the control.  Desmethyl-chlordimeform, a putative agonist, 
would be beneficial to test in this assay to see if the stimulatory effects were similar 
to carvacrol.  Phentolamine, a nonselective α-adrenergic receptor antagonist and 
also an antagonist of octopamine receptors was screened in our assay [39].  
Phentolamine interacted with Pa oa1, leading to partial inactivation of the G-protein 
to decrease cellular growth (Figure 6).  This decrease in cellular growth may indicate 
that there are few true neutral antagonists, and most are inverse agonists [34]. 
  A variety of monoterpenoids were screened in our assay (Figure 7, Table 3), 
and several of these compounds did not significantly affect growth, and thereby had 
apparently not interacted with the expressed Pa oa1.  However, some 
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monoterpenoids did alter Pa oa1, leading to a significantly decrease in yeast cell 
growth when compared to the vehicle control.  Previously, pulegone was reported as 
an antagonist, and limonene was reported as having no effect [16].  We are 
reporting both of these compounds, along with 1,4-cineol, citronellic acid, and 
camphor to be inverse agonists in this system.  When aromatic compounds were 
investigated, more diverse effects on Pa oa1 interaction was observed (Figure 8 and 
Table 3).  Carvacrol is the only compound to show a stimulatory effect on Pa oa1, 
thereby resulting in yeast cell growth exceeding that of the control (Figure 8 and 
Table 3).  This effect of carvacrol has been previously reported [16].  However, since 
octopamine did not cause any significant increase in growth it may be possible that 
carvacrol is interacting with Pa oa1 at an allosteric site.  Eugenol is another aromatic 
compound that has been investigated for its octopaminergic capabilities.  It has been 
reported as an antagonist in binding studies using American cockroach brain 
homogenates [16].    However, this report was countered by electrophysiological 
data at the DUM neurons where eugenol did not behave like an agonist or 
antagonist.  Instead eugenol decreased spontaneous nerve pulses, leading to the 
possibility that eugenol acts as an inverse agonist [19].  This assumption, that 
eugenol exerts its actions as an inverse agonist, matches our results of eugenol 
decreasing yeast cell growth by interacting with Pa oa1 (Figure 8 and Table 3).  In a 
separate study, when Pa oa1 was expressed in HEK-293 cells, eugenol decreased 
basal levels of cAMP, again consistent with to what we report here.  However, in the 
same cells, eugenol led to an increase in calcium release [17].  Agonist-specific 
coupling has been suggested for some GPCRs [49].  These receptors have the 
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ability to respond differentially to the ligand thereby activating different second 
messenger pathways.  Therefore, it is possible that eugenol would have an inhibitory 
effect on cAMP production but stimulate the liberation of intracellular calcium.  We 
are only observing the inhibitory action of eugenol in our constitutively active assay. 
Tables 4 and 5, display a comparison of monoterpenoids and aromatic compounds 
and their interaction with the octopamine receptor from the American cockroach [16, 
19].  The most significant comparison that can be concluded from Tables 4 and 5 is 
that compounds that were listed as antagonists were re-classified as inverse 
agonists with our assay.   
A variety of chemical structures for related aromatic compounds with various 
functional groups were used in this study including: acids, aldehydes, hydrocarbons, 
ethers, esters, and hydroxyls (Figure 2).  It has been suggested that a hydroxyl 
group increases the interaction between ligand and receptor [17].  However, one 
exception was noted, with p-cymene displaying a significant decrease in growth 
presumably by interaction with Pa oa1.  One interesting result that was obtained is 
the difference of the interaction of the isomers thymol and carvacrol.  Thymol did not 
interact with Pa ao1 and thereby did not alter the growth.  However, carvacrol did 
interact with Pa oa1 and significantly increased growth of yeast cells, the only 
compound found to have such an effect.  Saffrole which is structurally similar to 
piperonal (replacement of a propene group with a carboxyaldehyde) also showed 
significantly different interactions, and the presence of the carboxyaldehyde 
increased the ability of this compound to inhibit the activity of Pa oa1 (Figure 8 and 
Table 3).  Significant structural differences are also present in the monoterpenoids 
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that were screened in this study.  Functional groups include acid, ether, hydroxyl, 
ketone, and epoxide (Figure 1).  Some of the compounds lacked a hetero atom 
(aliphatic), and some were acyclic (citronellic acid and linalool).  A subtle difference, 
such as the connection of the cyclic ether in 1,8- and 1,4-cineole resulted in a 
significant difference in interaction with Pa oa1.  The presence of an epoxide group 
decreased the ability of limonene epoxide to interact with Pa oa1 when compared to 
limonene.  Finally, the two ketones (camphor and pulegone) that were tested in this 
study show significant interaction with Pa oa1, thereby caused a decrease in growth 
(Figure 7 and Table 2). 
The purpose of this study was to express Pa oa1 in the yeast, S. cerevisiae, 
to develop a high-throughput screening system to determine the efficacy of 
monoterpenoids and aromatic compounds from plant essential oils.  This screening 
system does not address the second messengers produced as a result of ligand-
receptor coupling.  However, the screening system can be a powerful tool to the 
agrochemical industry to screen a large number of compounds or essential oils to 
determine their efficacy at an isolated receptor and identify lead compounds.  
There is no evidence that octopamine receptors are constitutively active in the 
American cockroach.  Instead constitutive activity is an artifact of heterologous 
expression in yeast [35].  Some of the compounds have been reported to decrease 
basal levels of second messengers; it is possible that these compounds would inhibit 
the endogenous activity of octopamine.  Toxicity studies are currently being 
performed in our laboratory to determine if there is a correlation between the 
octopaminergic activities of the tested compounds on this receptor and the whole-
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insect toxicity.  Development of quantitative structure activity relationship (QSAR) 
models will provide insight into the physicochemical properties that are important to 
octopaminergic activity.  Future studies on a different chimeric yeast strain may 
provide a ligand-dependent model to screen agonist activity against this receptor.   
It is possible that these compounds have a variety of mode of actions in 
insects and ticks.  Some of the compounds that do not seem to affect octopamine do 
show other neurological interactions.  Natural product mixtures may result in more 
efficacious insecticides/acaracides, but this has not been fully investigated to date. 
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Figure 2.  Aromatic compound structures.  
found in plant essential oils that were screened against the 
octopamine receptor from the American cockroach (Pa oa1).
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Structures of aromatic compounds 
α-adrenergic
 
 
 
-like 
Figure 3.  Agarose gel of octopamine receptor gene
using a “Bust n’ Grab” method.  PCR amplification was performed with gene
primers for the α-adrenergic
100-base-pair DNA ladder (Invitrogen).  The top band is approximately 2 kilobases.  
The known size of Pa oa1 is 1.9 kb, which is the approximate size of the band 
shown in the middle pannel.  A negative control was performed with a cell 
transformed with an empty vector sh
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-specific 
 Figure 4.  Concentration dependent binding of octopamine competitive 
binding.  Competitive binding experiments were performed with 
yeast membrane preparations.  A functional 
was expressed at the yeast cell membrane.  A concentration dependent decrease of 
3H-octopamine binding is observed with increasing concentrations of un
octopamine. 
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Figure 5.  Growth responses of biogenic amines.  Growth effect of biogenic 
amines, octopamine and tyramine, on yeast expressing Pa oa1.  Octopamine and 
tyramine do not alter the level of growth, compared to the control (vehicle).   
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Figure 6.  Growth responses of octopaminergic compounds.  Effect of the 
octopaminergics: octopamine, phentolamine, synephrine, and chlordimeform on 
growth of yeast expressing Pa oa1 (*** indicates a p-value < 0.001; ANOVA). 
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Figure 7.  Growth responses to monoterpenoids.  Effect of plant monoterpenoids 
on growth of yeast cells expressing Pa oa1 (* indicates a p-value 0.01 - 0.05; ** 
indicates a p-value 0.01 - 0.001; *** indicates a p-value < 0.001; ANOVA). 
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Figure 8.  Growth responses to aromatic compounds.  Effect of plant aromatic 
compounds on the growth of yeast cells expressing Pa oa1 (* indicates a p-value 
0.01 – 0.05; ** indicates a p-value 0.01 - .005; *** indicates a p-value < 0.001; 
ANOVA).  
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Table 1.  Genotypes of yeast strains.  Genotypes of S. cerevisiae cells expressing 
Pa oa1 to use in histidine-auxotrophic assays.   
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Table 2.  Growth responses of monoterpenoids.  Effects that plant 
monoterpenoids have on the growth of yeast cells expressing Pa oa1. 
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Table 3.  Growth response of aromatic compounds.  Effects of plant aromatic 
compounds have on the growth of yeast cells expressing Pa oa1. 
 
  
75 
 
 
Table 4.  Literature comparison of monoterpenoid compounds.  Comparison of 
the effect of monoterpenoids tested in the yeast growth experiments.  Data was 
compared to earlier studies on the same receptor. 
  
76 
 
 
Table 5.  Literature comparison of aromatic compounds.  Comparison of 
aromatic compounds tested in yeast growth experiments.  Data was compared to 
other studies on the same receptor. 
  
77 
 
CHAPTER 3. General Conclusions 
Maintaining the viability of the world’s food supply and controlling arthropod-
borne disease have been achieved through chemical insecticides.   Increased 
restrictions and insect resistance have decreased the availability of some 
conventional synthetic insecticides creating the opportunity for new safer 
compounds.  This decrease is a result of public concern about the adverse side 
effects, environmental risk of some conventional products, and reduced efficacy 
against resistant strains of insects.  Botanicals, particularly essential oils and their 
constituents have emerged as insecticidal compounds with great potential.  These 
compounds are suitable as they have a broad spectrum of activity amongst insect 
pests and have an increased safety ratio for both the user and the environment 
(Tsao and Coats 1995, Lee et al. 1997, Isman 2000, Isman 2006).  Like any 
chemical application to control insects of either agricultural or public heath, a 
botanical product can be a component, not the sole tactic, of an integrated pest 
management approach.   
In Chapter 2 and the appendix I used a heterologous expression system, the 
yeast Saccharomyces cerevisiae, to examine the efficacy of natural products at an 
insect nervous system target, an α-adrenergic-like octopamine receptor.  I have 
shown that a variety of essential oil constituents have the ability to interact with the 
octopamine receptor.  Toxicity of the compounds to insects is currently being 
performed to understand toxicity and any correlation with effects at an octopamine 
receptor.   The compounds that are presented in Chapter 2 and the appendix are 
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meant to be a starting point in the discovery of new compounds as many other 
compounds are commercially available or can be purified from the oils.  Possible 
biorational synthetic analogues may also be developed, potentially with enhanced 
activity at this receptor, thereby leading to increased insecticidal potency.  
In Chapter 2, 11 monoterpenoids and 11 related aromatic compounds were 
screened for their ability to interact with an octopamine receptor (Pa oa1).  Of the 22 
compounds 14, nine of which were aromatic compounds, showed a significant 
interaction with Pa oa1.  In the appendix, eight sesquiterpenoids compounds were 
screened of which six had significant interaction with Pa oa1.  It has been suggested 
that aromatic compounds may be more effective insecticides (Enan 2001), which is 
consistent with the activity seen with Pa oa1.   
It has long been appreciated that minor changes in chemical structure, such 
as orientation of heteroatoms, can lead to significant changes in the efficacy at a 
target.  Quantitative structure-activity relationships (QSAR) models will be used to 
understand important chemical characteristics for interaction with this octopamine 
receptor.  QSAR models will be built by using the activity of these compounds at Pa 
oa1 that may allow for the prediction of octopaminergics of increased potency.  
Botanical products are slowly emerging in the market place due to their 
insecticidal usefulness (Isman 2000, Isman 2006).  Increased knowledge about the 
safety and risk assessment of these compounds, environmental impacts, and 
responsible uses are essential and need to be provided to the consumer.  Increased 
knowledge of the mode of action will result in more effective applications.  The 
modes of action of essential oil constituents may be as diverse as their chemical 
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structures.  Here I report on a few of the monoterpenoids, sesquiterpenoids, and 
aromatic compounds available and their ability to interact with an octopamine 
receptor.  Essential oil constituents may have multiple modes of action, which may 
be beneficial and may offer the opportunity for different applications such as 
synergistic mixtures and should be investigated further.  Development of new 
insecticides has long been a “shot-gun approach or fishing expedition” focused on 
the same modes of action (Caveney and Cameron Donly 2002).  However, 
understanding the biology of novel targets may give rise to effective compounds and 
targets previously not utilized. 
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APPENDIX. The ability of sesquiterpenoids to interact with a 
ligand-independent α-adrenergic–like octopamine receptor from 
the American cockroach, Periplaneta americana 
Background Information 
Increased public concern about the safety of conventional insecticides has 
resulted in increased governmental restrictions (e.g. Food Quality Protection Act of 
1996) affecting the availability and use of some insecticides/acaricides.  Concern 
over conventional insecticides leaves an opportunity for new, safe, and effective 
compounds to control pests important in agriculture and public health (Isman 2000, 
Isman 2006).  Botanical products can offer a safe and environmentally friendly 
alternative to conventional insecticides.  Essential oils are complex mixtures of 
terpenes/terpenoids and related aromatic compounds that plants have developed to 
prevent herbivory, disease, and interspecies competition.  “Terpene” will be used 
interchangeably with “terpenoid” in this report.  While monoterpenoids and related 
aromatic compounds have previously been investigated for their toxic activity against 
insects in our laboratory, little information is available on the insecticidal activity of 
sesquiterpenoids (Rice and Coats 1994, Tsao and Coats 1995, Lee et al. 1997, 
Fassbinder et al. 2002).  Research on sesquiterpenoids has primarily been focused 
on insect behavioral changes such as repellency (Paluch et al. 2009a, Paluch et al. 
2009b).  Similar to monoterpenoids, sesquiterpenoids are biosynthesized from 
isoprene units, which are 5-carbon building blocks.  Coupling of three isoprene units 
results in the basic structure of a sesquiterpenoid.  These isoprene backbones are 
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targeted by various enzymes to create functional groups and or cyclic structures 
(Chappell 1995, Dewick 1997, Croteau et al. 2000). 
Octopamine is an important biogenic monoamine in invertebrates and, 
therefore has significant physiological actions in insects (Roeder 1999, Roeder et al. 
2003, Roeder 2005, Farooqui 2007).  Octopamine exerts its physiological actions 
through G-protein-coupled receptors (GPCRs) (Blenau and Baumann 2001).  
Octopamine receptors are classified based on sequence similarity between 
Drosophila melanogaster octopamine receptors and the mammalian adrenergic 
receptors. This has resulted in the identification of three octopamine receptors: (1) α-
adrenergic-like octopamine receptor, which can trigger an increase in intracellular 
calcium,  (2) β-adrenergic-like octopamine receptor, which generates an increase 
the intracellular level of cyclic adenosine monophosphate (cAMP), (3) 
tyramine/octopamine receptor that can bind either ligand but displays ligand-
dependent signaling activity (Evans et al. 1995).  When octopamine is the ligand, the 
tyramine/octopamine receptor triggers an increase in intracellular levels of calcium 
but tyramine has an inhibitory effect on adenylate cyclase, which causes a decrease 
in cAMP  (Evans and Maqueira 2005, Farooqui 2007).  Octopamine receptors have 
been identified as the site of action of the formamidine class of insecticides (Evans 
and Gee 1980, Nathanson and Hunnicutt 1981, Gole et al. 1983, Davenport et al. 
1985, Orr et al. 1990, Li et al. 2004).  Insecticides at this target would be 
advantageous since the receptor does not share significant physiological functions in 
vertebrates. 
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Saccharomyces cerevisiae, referred to as yeast hereafter, has emerged as an 
important organism to study heterologously expressed GPCRs ((Bardwell 2005, 
Minic et al. 2005)).  Functional expression of heterologous GPCRs can be achieved 
by linking the expressed receptor to the yeast’s endogenous pheromone response 
pathway, which has been performed with multiple mammalian GPCRs (Minic et al. 
2005) and some invertebrate GPCRs (Kimber et al. 2009, Taman and Ribeiro 2009).   
In this appendix we will utilize the high-throughput screening system that is 
described in Chapter 2 to determine the activity of sesquiterpenoids from plant 
essential oils. 
Materials and Methods 
The materials and methods for the expression of Pa oa1 in the American 
cockroach are identical to Chapter 2 materials and methods.  The sesquiterpenoids 
caryophyllene, caryophyllene oxide, cedrol, methyl cedryl ketone, cedryl acetate, 
and methyl cedryl ether were purchased from Sigma (St. Louis, MO); the structures 
of these compounds are shown in Figure 1.  Guaiol was obtained from guaiacwood 
concrete (Ungerer and Company; Lincoln park NJ) and purified using column 
chromatography with silica gel to achieve a purity of greater than 90%.  Compounds 
were dissolved in dimethyl sulfoxide (DMSO) and serial diluted to 1 x 10-4 M for 
screening purposes.  The final concentration of DMSO to which the cells were 
exposed was less than 1%. 
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Preliminary Results  
Expression of Pa oa1 in the yeast S. cerevisiae 
Expression of our isolated octopamine gene was performed using a lithium 
acetate method (Gietz et al. 1995).  The presence of the octopamine receptor open 
reading frame was confirmed by performing PCR with gene-specific primers.  The 
resulting amplicon is approximately 2 kb, with Pa oa1 size reported to be 1.9 kb 
(Bischof and Enan 2004) as shown in Chapter 2, Figure 3. The presence of the gene 
does not guarantee that a functional receptor is expressed at the membrane, as it 
has been previously reported that heterologous receptors can be maintained in 
intracellular compartments and possibly degraded (Bardwell 2005).  To confirm the 
presence of a functional receptor, radioligand binding with 3H-octopamine was 
performed.  A concentration-dependent decrease in radioligand binding was 
observed with increasing concentrations of un-labeled octopamine (Chapter 2, 
Figure 4).   
The isolated American cockroach octopamine receptor was expressed in a 
variety of genetically modified yeast cells (Chapter 2, Table 1).  Each cell line was 
transformed with Pa oa1 to find a cell line suitable to perform a histidine-auxotrophic 
assay (Wang et al. 2006, Kimber et al. 2009, Taman and Ribeiro 2009).  In this 
assay the heterologous receptor (Pa oa1) is linked to the endogenous yeast 
pheromone pathway.  Activation of this pathway results in the expression of the 
pheromone responsive element, fus1, a promoter gene leading to the activation of a 
his3 reporter gene allowing the production of histidine.  Therefore, cells that are 
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present in histidine-deficient medium cannot perform necessary protein synthesis 
unless histidine is added to the medium or there is induction of histidine synthesis. 
Octopamine was previously identified as a ligand for Pa oa1 (Bischof and 
Enan 2004); however, octopamine does not affect the growth of yeast expressing 
this receptor (Chapter 2, Figure 5).  Tyramine, the immediate synthetic precursor to 
octopamine, also did not affect growth (Chapter 2, Figure 5).  This led us to 
hypothesize that Pa oa1 displays ligand-independent activity since growth is 
significantly enhanced in CY18043 when compared to other cell lines (data not 
shown).  Pa oa1 activity seems to be partially inactivated by previously identified 
compounds that interact with octopamine receptors (octopaminergics), as shown in 
Chapter 2, Figure 6.  Phentolamine, synephrine, and chlordimeform interacted with 
Pa oa1 initiating an inactive state of the heterotrimeric G-protein.   
A variety of plant sesquiterpenoids were tested against the isolated receptor, 
Pa oa1, to determine if they showed any activity against this receptor.  Figure 2 and 
Table 1 show several sesquiterpenoids that interacted with Pa oa1 and act as 
inverse agonists or have an inhibitory effect, thereby significantly decreasing growth.  
The compounds that decreased growth include cedrol (p-value 0.01-0.05), methyl 
cedryl ketone (p-value < 0.001), caryophyllene (p-value < 0.001), methyl cedryl ether 
(p-value < 0.001), nootkatone (p-value < 0.001), and cedryl acetate (p-value < 
0.001).  Two of the eight test compounds (caryophyllene oxide and guaiol) did not 
significantly alter growth, thereby indicating a poor interaction with Pa oa1.   
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Discussion 
An engineered yeast cell line (CY18043) was used to screen the capacity of a 
variety of compounds to interact with Pa oa1.  Phentolamine, synephrine, and 
chlordimeform have been shown to interact with octopamine receptors and were 
screened in our assay (Nathanson and Hunnicutt 1981, Robb et al. 1994, Bischof 
and Enan 2004, Enan 2005).  These compounds interact with Pa oa1 to decrease 
yeast cell growth or act as inverse agonist against this receptor (Chapter 2, Figure 
6).  This interaction with Pa oa1 and inactivation of the heterotrimeric G-protein 
substantiates our claim that Pa oa1 is displaying ligand-independent activity, 
allowing a system to screen for inverse agonists at this receptor. 
The compounds that were tested in this study had various functional groups 
such as epoxide, hydroxyl, methyl ketone, methyl ether, and acetate (Figure 1).  All 
of the compounds share a 15-carbon structural backbone but electronegative atoms 
are not present in all compounds (e.g. caryophyllene).  The presence of a 
heteroatom was not essential to interact with Pa oa1 thereby causing a functional 
result.  Some sesquiterpenoids presented here were tested for their efficacy as 
repellents but their toxicity is not well understood (Paluch et al. 2009a).  There were 
two ketones tested in our assay, nootkatone and methyl cedryl ketone, but 
nootkatone was more effective at causing a significant decrease in growth.  The two 
compounds that possess hydroxyl groups (cedrol and guaiol) had different effects on 
Pa oa1 with cedrol leading to a significant change in growth (Figure2 and Table 1). 
 The purpose of this study was to express Pa oa1 in the yeast, S. cerevisiae, 
to develop a ligand-independent high-throughput screening system to determine the 
87 
 
efficacy of sesqiterpenoids from plant essential oils.  This screening system does not 
address the second messenger production as a result of ligand-receptor coupling.  
However, the screening system can be a powerful tool to the agrochemical industry 
to screen a large number of lead compounds to determine their efficacy at a 
heterologously expressed receptor. There is no evidence that octopamine receptors 
are constitutively active in the American cockroach.  Instead, constitutive activity is 
assumed to be  an artifact of heterologous expression in yeast (Bardwell 2005).  
Toxicity studies of these compounds against the American cockroach are currently 
being performed in our laboratory, and we have found that some sesquiterpenoids 
have lethal activity (data not shown).  Nootkatone has recently been reported to 
suppress and control populations of Ixodes scapularis and Amblyomma americanum 
in field trials (Dolan et al. 2009).  Further research is needed to determine the 
toxicological efficacy of the individual sesquiterpenoids compounds.  Quantitative 
structure-activity relationship (QSAR) models are expected to be generated to share 
insight into the physciochemical properties that are important to octopaminergic 
activity.  Future studies on a different chimeric yeast strain may provide a ligand-
dependent model to screen agonist activity against this receptor.   
It is possible that sesquiterpenoids have multiple of modes of actions.  Some 
of the compounds that do not seem to affect the octopamine receptor still exhibit 
neurological symptomologies.  It may be possible that some the natural product 
mixtures may lead to more efficacious insecticides/acaracides but this has not been 
fully investigated to date. 
88 
 
Acknowledgments 
The authors thank Dr. James Broach, Princeton University, for the yeast 
strains used in this study.  We express our sincere thanks to Matthew Vandehaar 
and Dana McKeever for their assistance in the isolation of sesquiterpenoids from 
plant oils.  This study was funded by the Center for Disease Control and Prevention 
(CDC), Atlanta GA, and Fort Collins, CO., contract number 200-2008-28189. 
 
 
  
89 
 
References 
Bardwell, L. 2005. A walk-through of the yeast mating pheromone response 
pathway. Peptides 26: 339-50. 
Bischof, L. J., and E. E. Enan. 2004. Cloning, expression and functional analysis of 
an octopamine receptor from Periplaneta americana. Insect Biochemistry and 
Molecular Biology 34: 511-521. 
Blenau, W., and A. Baumann. 2001. Molecular and pharmacological properties of 
insect biogenic amine receptors: lessons from Drosophila melanogaster and 
Apis mellifera. Archives of Insect Biochemistry and Physiology 48: 13-38. 
Chappell, J. 1995. Biochemistry and molecular-biology of the isoprenoid 
biosynthetic-pathway in plants. Annual Review of Plant Physiology and Plant 
Molecular Biology 46: 521-547. 
Croteau, R., T. M. Kutchan, and N. G. Lewis. 2000. Natural products (secondary 
metabolites), pp. 1250-1269. In B. Buchanan, W. Grussern and R. Jones 
[eds.], Biochemistry and Molecular Biology of Plants. John Wiley & Sons INC, 
Somerset, NJ. 
Davenport, A. P., D. B. Morton, and P. D. Evans. 1985. The action of 
formamidines on octopamine receptors in the locust. Pesticide Biochemistry 
and Physiology 24: 45-52. 
Dewick, P. M. 1997. Medicinal Natural Products: A Biosynthetic Approach. John 
Wiley & Sons, LTD, West Sussex. 
 
90 
 
Dolan, M. C., R. A. Jordan, T. L. Schulze, C. J. Schulze, M. C. Manning, D. 
Ruffolo, J. P. Schmidt, J. Piesman, and J. J. Karchesy. 2009. Ability of two 
natural products, nootkatone and carvacrol, to suppress Ixodes scapularis 
and Amblyomma americanum (Acari: Ixodidae) in a Lyme disease endemic 
area of New Jersey. Journal of Economic Entomology 102: 2316-24. 
Enan, E. E. 2005. Molecular and pharmacological analysis of an octopamine 
receptor from American cockroach and fruit fly in response to plant essential 
oils. Archives of Insect Biochemistry and Physiology 59: 161-171. 
Evans, P. D., and J. D. Gee. 1980. Action of formamidine pesticides on octopamine 
receptors. Nature 287: 60-62. 
Evans, P. D., and B. Maqueira. 2005. Insect octopamine receptors: a new 
classification scheme based on studies of cloned Drosophila G-protein 
coupled receptors. Invertebrate Neuroscience 5: 111-118. 
Evans, P. D., S. Robb, T. R. Cheek, V. Reale, F. L. Hannan, L. S. Swales, L. M. 
Hall, and J. M. Midgley. 1995. Agonist-specific coupling of G-protein coupled 
receptors to multiple second messenger systems, pp. 81-90. In P. M. Yu, K. 
F. Tipton and A. A. Boulton [eds.], Progress in Brain Research. Elsevier 
Science. 
Farooqui, T. 2007. Octopamine-mediated neuromodulation of insect senses. 
Neurochemical Research 32: 1511-1529. 
Fassbinder, C., J. Grodnitzky, and J. Coats. 2002. Monoterpenoids as possible 
control agents for Varroa destructor. Journal of Apicultural Research 41: 83-
88. 
91 
 
Gietz, R. D., R. H. Schiestl, A. R. Willems, and R. A. Woods. 1995. Studies on the 
transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. 
Yeast 11: 355-360. 
Gole, J. W. D., G. L. Orr, and R. G. H. Downer. 1983. Interaction of formamidines 
with octopamine-sensitive adenylate cyclase receptor in the nerve cord of 
Periplaneta americana. Life Sciences 32: 2939-2947. 
Isman, M. B. 2000. Plant essential oils for pest and disease management. Crop 
Protection 19: 603-608. 
Isman, M. B. 2006. Botanical insecticides, deterrents, and repellents in modern 
agriculture and an increasingly regulated world. Annual Review of 
Entomology 51: 45-66. 
Kimber, M. J., L. Sayegh, F. El-Shehabi, C. Song, M. Zamanian, D. J. Woods, T. 
A. Day, and P. Ribeiro. 2009. Identification of an Ascaris G protein-coupled 
acetylcholine receptor with atypical muscarinic pharmacology. International 
Journal for Parasitology 39: 1215-1222. 
Lee, S., R. Tsao, C. Peterson, and J. R. Coats. 1997. Insecticidal activity of 
monoterpenoids to western corn rootworm (Coleoptera:Chrysomelidae), 
twospotted spider mite (Acari:Tetranychidae), and house fly 
(Diptera:Muscidae). Journal of Economic Entomology 90: 883-892. 
Li, A. Y., R. B. Davey, R. J. Miller, and J. E. George. 2004. Detection and 
characterization of amitraz resistance in the southern cattle tick, Boophilus 
microplus (Acari : Ixodidae). Journal of Medical Entomology 41: 193-200. 
92 
 
Minic, J., M. Sautel, R. Salesse, and E. Pajot-Augy. 2005. Yeast system as a 
screening tool for pharmacological assessment of g protein coupled 
receptors. Current Medicinal Chemistry 12: 961-9. 
Nathanson, J. A., and E. J. Hunnicutt. 1981. N-Demethylchlordimeform: A potent 
partial agonist of octopamine-sensitive adenylate cyclase. Molecular 
Pharmacology 20: 68-75. 
Orr, G. L., N. Orr, L. Cornfield, J. W. D. Gole, and R. G. H. Downer. 1990. 
Interaction of formamidine pesticides with insect neural octopamine receptors: 
Effects on radioligand binding and cyclic AMP production. Pesticide Science 
30: 285-294. 
Paluch, G., J. Grodnitzky, L. Bartholomay, and J. Coats. 2009a. Quantitative 
structure-activity relationship of botanical sesquiterpenes: Spatial and contact 
repellency to the yellow fever mosquito, Aedes aegypti. Journal of Agricultural 
and Food Chemistry 57: 7618-7625. 
Paluch, G., E., J. Zhu, L. Bartholomay, and R. Coats Joel. 2009b. Amyris and 
Siam-wood essential oils: Insect activity of sesquiterpenes, pp. 5-18. In C. J. 
Peterson and D. M. StoutII [eds.], Pesticides in Household, Structural and 
Residential Pest Management. American Chemical Society, Washington, DC. 
Rice, P. J., and J. R. Coats. 1994. Insecticidal properties of monoterpenoid 
derivatives to the house fly (Diptera: Muscidae) and red flour beetle 
(Coleoptera: Tenebrionidae). Pesticide Science 41: 195-202. 
93 
 
Robb, S., T. R. Cheek, F. L. Hannan, L. M. Hall, J. M. Midgley, and P. D. Evans. 
1994. Agonist-specific coupling of a cloned Drosophila octopamine/tyramine 
receptor to multiple second messenger systems. EMBO Journal 13: 1325-30. 
Roeder, T. 1999. Octopamine in invertebrates. Progress in Neurobiology 59: 533-
561. 
Roeder, T. 2005. Tyramine and octopamine: Ruling behavior and metabolism. 
Annual Review of Entomology 50: 447-477. 
Roeder, T., M. Seifert, C. Kähler, and M. Gewecke. 2003. Tyramine and 
octopamine: Antagonistic modulators of behavior and metabolism. Archives of 
Insect Biochemistry and Physiology 54: 1-13. 
Taman, A., and P. Ribeiro. 2009. Investigation of a dopamine receptor in 
Schistosoma mansoni: Functional studies and immunolocalization. Molecular 
and Biochemical Parasitology 168: 24-33. 
Tsao, R., and J. R. Coats. 1995. Starting from nature to make better insecticides. 
Chemtech 25: 23-28. 
Wang, Z. X., J. R. Broach, and S. C. Peiper. 2006. Functional expression of 
CXCR4 in Saccharomyces cerevisiae in the development of powerful tools for 
the pharmacological characterization of CXCR4. Methods in Molecular 
Biology 332: 115-27. 
 
 
  
 Figure 1.  Sesquiterpenoid structure
plant essential oils that were screened against the ligand
like octopamine receptor from the American cockroach (Pa oa1).
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Figure 2.  Growth responses of sesquiterpenoids.  Effect of plant 
sesquiterpenoids on growth of yeast cells expressing Pa oa1 (* indicates a p-value 
0.01 - 0.05; ** indicates a p-value 0.01 - 0.001; *** indicates a p-value < 0.001; 
ANOVA). 
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Table 1.  Growth responses of sesquiterpenoids.  Effects of plant 
sesquiterpenoids on the growth of yeast cells expressing Pa oa1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
